| 1 | [SID49818988] | Active | AC50 | 7.55 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | AC50 | 7.55 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID49818988] | Active | AC50 | 8.31 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | AC50 | 8.31 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID49818988] | Active | Potency | 12.9953 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID49818988] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID49818988] | Active | Potency | 20.5962 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 6 | [SID49818988] | Active | | | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels [AID651746, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 651746 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 7 | [SID49818988] | Active | | | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels [AID651746, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 651746 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 8 | [SID49818988] | Active | | | Validation (re-confirmation) assay for identification of compounds that inhibit KCNQ1 potassium channels [AID588353, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Validation (re-confirmation) assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 588353 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 9 | [SID49818988] | Active | | | Counter screen assay of the parental CHO cells for identification of compounds that inhibit KCNQ1 potassium channels [AID588366, Type: other] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Counter screen assay of the parental CHO cells for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 588366 | | BioAssay type | other | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 10 | [SID49818988] | Active | | | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) [AID588511, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) | | AID | 588511 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 11 | [SID49818988] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 12 | [SID49818988] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 13 | [SID49818988] | Active | | | Single concentration confirmation of small molecule inhibitors of tim10-1 yeast via a luminescent assay [AID463213, Type: screening] | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule inhibitors of tim10-1 yeast via a luminescent assay | | AID | 463213 | | BioAssay type | screening | | Target | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] | | PubMed | | | Data Table |  |
|
| 14 | [SID49818988] | Active | | | Single concentration confirmation of small molecule inhibitors of tim10 yeast via a luminescent assay [AID463215, Type: screening] | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule inhibitors of tim10 yeast via a luminescent assay | | AID | 463215 | | BioAssay type | screening | | Target | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] | | PubMed | | | Data Table |  |
|
| 15 | [SID49818988] | Active | | | uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay [AID463190, Type: screening] | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay | | AID | 463190 | | BioAssay type | screening | | Target | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] | | PubMed | | | Data Table |  |
|
| 16 | [SID49818988] | Active | | | uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay [AID463195, Type: screening] | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay | | AID | 463195 | | BioAssay type | screening | | Target | TPA: Tim10p [Saccharomyces cerevisiae S288c] [gi:285809906] | | PubMed | | | Data Table |  |
|
| 17 | [SID49818988] | Active | | | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): Luminescence-based cell-based high throughput screening assay to identify agonists of the Herpes Virus Virion Protein 16 (VP16) [AID624379, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): Luminescence-based cell-based high throughput screening assay to identify agonists of the Herpes Virus Virion Protein 16 (VP16) | | AID | 624379 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 18 | [SID49818988] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 19 | [SID49818988] | Active | | | uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay [AID463212, Type: screening] | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay | | AID | 463212 | | BioAssay type | screening | | Target | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] | | PubMed | | | Data Table |  |
|
| 20 | [SID49818988] | Active | | | Single concentration confirmation of small molecule inhibitors of tim23-1 yeast via a luminescent assay [AID463218, Type: screening] | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule inhibitors of tim23-1 yeast via a luminescent assay | | AID | 463218 | | BioAssay type | screening | | Target | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] | | PubMed | | | Data Table |  |
|
| 21 | [SID49818988] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 22 | [SID49818988] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 23 | [SID49818988] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 24 | [SID49818988] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 25 | [SID49818988] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 26 | [SID49818988] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 27 | [SID49818988] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 28 | [SID49818988] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 29 | [SID49818988] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 30 | [SID49818988] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2233 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 31 | [SID49818988] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2233 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 32 | [SID49818988] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 33 | [SID49818988] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 34 | [SID49818988] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID49818988] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay [AID624504, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay | | AID | 624504 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID49818988] | Active | | | Specificity screen against KCNQ1/KCNE1 for identification of compounds that inhibit KCNQ1 potassium channels [AID652147, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ1/KCNE1 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 652147 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID49818988] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 38 | [SID49818988] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2232, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2232 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 39 | [SID49818988] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID49818988] | Active | | | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line [AID602250, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line | | AID | 602250 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID49818988] | Active | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID49818988] | Active | | | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity [AID651610, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651610 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID49818988] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 44 | [SID49818988] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 45 | [SID49818988] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 46 | [SID49818988] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 47 | [SID49818988] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 48 | [SID49818988] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 49 | [SID49818988] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 50 | [SID49818988] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49818988 | | CID | 24817742 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|